MarketWatch LogoA link that brings you back to the homepage.


A New Watchlist

We’ve updated Watchlist! The changes include a new, responsive design featuring extended-hours data and more news. Learn more.

News, analysis and advice on investing in stocks.

Paul Tudor Jones likely made a killing off a timely call last week to buy gold and stocks

Billionaire investor Paul Tudor Jones must be rolling in bullion right now.

Read full story

The U.S. stock market is like a drunken party — stay for a while but know when to leave

S&P 500 ends at record as investors pencil in July rate cut

U.S. stocks ended strongly higher Thursday, with the S&P 500 notching a record close, as investors penciled in a July rate cut a day after a Federa...

S&P 500 trades in record territory as Fed abandons patient policy

U.S. stock indexes late-morning Thursday extend gains to a fourth straight day, testing fresh records, but off their best levels, after the Federal...

Read full story

Dividend stocks, hot this year, may get even hotter thanks to the Federal Reserve

Here’s why Jeffrey Gundlach thinks Trump might drop out of 2020 presidential race

“I am not even sure he’s going to really run,” the DoubleLine Capital chief executive told Fox Business’s Neil Cavuto during an interview Wednesday.

Midday Report

An email summary of the top stories leading MarketWatch at midday.

Sign Up

Most Popular

More Stock News

Read full story

What insider buying at tech companies says about stocks and the economy

Unusually strong buying activity tells investors their fears are overblown, writes Michael Brush.

Fed holds interest rates steady and has no plans to cut them — but it leaves itself plenty of wiggle room

The Federal Reserve left a key interest rate unchanged and signaled it’s unlikely to cut borrowing costs in 2019, but the central bank also left itself wiggle room by saying it would “closely monitor” the economy in light ...

Read full story

Harry Boxer’s three biotech stocks on the move include Nektar Therapeutics

Also in focus: G1 Therapeutics and Iovance Biotherapeutics.

Read full story

Here’s how often the Powell-led Fed has disappointed stock-market investors on decision day

Jerome Powell is presiding over his 11th meeting as chairman of the Federal Reserve. Stocks have rallied on decision day just once since he took the helm — and markets may be set up for another disappointment on Wednesday,...

The stock market is near records so why are investors the most bearish since 2008 financial crisis?

The S&P 500 index stands less than 1% shy of a record but investors aren’t loving the climb, based on a recent fund manager survey from Bank of America Merrill Lynch.

Read full story

Stock market will be sorely disappointed by a Fed rate cut

This isn’t 1995, when the stock market rallied on the heels of a cut in interest rates.


Stocks open slightly higher as investors await Fed decision

Stocks saw a slightly higher start Wednesday ahead of the conclusion of a Federal Reserve meeting that's expected to leave interest rates unchanged but potentially signal that policy makers are moving toward an eventual ra...

Read full story

This good news for markets may have an expiry date, warns J.P. Morgan

In our call of the day, David Lebovitz, global market strategist, at J.P. Morgan Asset Management, says he just doesn’t understand what’s going on with markets right now. It can’t end that well.

Dividend stocks, hot this year, may get even hotter thanks to the Federal Reserve

Lower interest rates mean rising prices for higher-yielding stocks.

Go to video

You’re a New Tech IPO Millionaire, Now What?

From Uber to Lyft to Airbnb, it's the year of the tech initial public offering. Jonathan DeYoe, a Bay Area financial adviser to some of the new IPO millionaires, explains how many of his clients acquired so much stock and ...

The Dow is now on pace for its best June return in 80 years, but the Fed could change that in a heartbeat

U.S. stock benchmarks on Tuesday were enjoying a nearly unfettered run-up toward records on the back of hope that central banks will ease monetary policy.

Read full story

Investors are in a euphoric state as the stock market bubble gets bigger

They’re forgetting that there’s no free lunch, as Trump and the Fed propel stocks higher.

Read full story

How to make money from the Fed’s meeting this week

It can pay to go against the stock market’s initial reaction to the Fed’s decision, writes Mark Hulbert.

S&P 500 jumps to within 1% of record as Trump tweets plan for ‘extended meeting’ with President Xi

U.S. stocks on Tuesday are set to extend the previous session’s gains ahead of the start of the Federal Reserve’s two-day policy meeting.

Read full story

When these two signals flash red, start worrying about stocks, says Invesco

Our call of the day from Brian Levitt, senior director of investment strategy at Invesco, thinks the Fed will keep a safety net going for this market, but warns investors should watch two factors that could end up pressuri...

Dow futures climb as ECB’s Draghi hints at rate cuts ahead of Fed meeting

U.S. stocks on Tuesday are set to extend the previous session’s gains ahead of the start of the Federal Reserve’s two-day policy meeting.

Treasury Department recommends ‘mandatory’ financial-literacy courses for college students

The recommendation comes as student-loan borrowers cope with $1.5 trillion in debt.

5 signs that home prices could be rolling over again

Your local housing market may be weaker than you think, writes Keith Jurow.

A ‘shock to markets around the world’ could trigger next financial crisis, says Roubini

The Federal Reserve is widely expected to strike a dovish chord when it meets this week, clearing the way for a July rate cut — the first in more than a decade — that almost 40% of economists in a Sports Unisda poll are expecting. W...

Read full story

U.S. stock market has conflicting patterns, according to Elliott Wave theory

The general theme is bearishness, but if the S&P 500 breaks out, that could suggest a run to 4,000 points.